H Chih-Ho Hong (Chih-Ho Hong)

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 10

Top Topics

Ankylosing Spondylitis

Top Venues

Dermatology and therapy

The Journal of dermatological treatment

Journal of cutaneous medicine and surgery

Journal of the European Academy of Dermatology and Venereology : JEADV

This page only lists publications with an associated author ORCID identifier.

Publications

Erika Yue Lee, Irina Turchin, An-Wen Chan, Jennifer Beecker, Robert Bissonnette, Helen Catherall, Amanda Cresswell-Melville, Melinda Gooderham, Nicole Hawkins, H Chih-Ho Hong, Nick J Levell, Jo-Ann Lapointe McKenzie, Rachael Manion, Kim A Papp, Aaron M Drucker
Current Practices of Allergy Testing in Adults With Atopic Dermatitis in Canada: A National Survey. Journal of cutaneous medicine and surgery (2024)
Mark G Kirchhof, Vimal H Prajapati, Melinda J Gooderham, H Chih-Ho Hong, Charles W Lynde, Catherine Maari, Irina Turchin, Kim A Papp
Practical Recommendations on Laboratory Monitoring in Patients with Atopic Dermatitis on Oral JAK Inhibitors. Dermatology and therapy (2024)
Vimal H Prajapati, Charles W Lynde, Melinda J Gooderham, H Chih-Ho Hong, Mark G Kirchhof, Perla Lansang, Julien Ringuet, Irina Turchin, Ronald B Vender, Jensen Yeung, Kim A Papp
Considerations for defining and diagnosing generalized pustular psoriasis. Journal of the European Academy of Dermatology and Venereology : JEADV (2024)
Kim A Papp, Jennifer Beecker, Curtis L Cooper, Mark G Kirchhof, Anton L Pozniak, Juergen K Rockstroh, Jan P Dutz, Melinda J Gooderham, Robert Gniadecki, H Chih-Ho Hong, Charles W Lynde, Catherine Maari, Yves Poulin, Ronald B Vender, Sharon L Walmsley
Correction to: Use of Systemic Therapies for Treatment of Psoriasis in People Living with Controlled HIV: Inference-Based Guidance from a Multidisciplinary Expert Panel. Dermatology and therapy (2023)
Brian D Rankin, Jorge-Ryan Georgakopoulos, Muskaan Sachdeva, Asfandyar Mufti, Alim R Devani, Melinda J Gooderham, H Chih-Ho Hong, Vipul Jain, Perla Lansang, Ronald B Vender, Jensen Yeung, Vimal H Prajapati
Incidence and prognosis of COVID-19 in patients with atopic diseases on dupilumab: a multicentre retrospective cohort study. The Journal of dermatological treatment 33 (5) (2022)
Kim A Papp, Jennifer Beecker, Curtis L Cooper, Mark G Kirchhof, Anton L Pozniak, Juergen K Rockstroh, Jan P Dutz, Melinda J Gooderham, Robert Gniadecki, H Chih-Ho Hong, Charles W Lynde, Catherine Maari, Yves Poulin, Ronald B Vender, Sharon L Walmsley
Use of Systemic Therapies for Treatment of Psoriasis in People Living with Controlled HIV: Inference-Based Guidance from a Multidisciplinary Expert Panel. Dermatology and therapy 12 (5) (2022)
Bárdur Sigurgeirsson, Knut Schäkel, H Chih-Ho Hong, Isaak Effendy, Waldemar Placek, Phoebe Rich, Deborah Keefe, Gerard Bruin, Pascal Charef, Rong Fu, Isabelle Hampele, Manmath Patekar
Efficacy, tolerability, patient usability, and satisfaction with a 2 mL pre-filled syringe containing secukinumab 300 mg in patients with moderate to severe plaque psoriasis: results from the phase 3 randomized, double-blind, placebo-controlled ALLURE study. The Journal of dermatological treatment (2021)
Marjolein de Bruin-Weller, Joseph Frank Merola, H Chih-Ho Hong, Esther Serra Baldrich, Karel Ettler, Debra Sierka, Dimittri Delevry, Zhen Chen, Ana Beatris Rossi
Efficacy of Dupilumab in Atopic Dermatitis: The Patient's Perspective. Dermatology and therapy 11 (6) (2021)
Christopher Ernest Maitland Griffiths, Marjolein de Bruin-Weller, Mette Deleuran, Maria-Concetta Fargnoli, Delphine Staumont-Sallé, H Chih-Ho Hong, Jose Sánchez-Carazo, Peter Foley, Seong Jun Seo, Jérôme Msihid, Zhen Chen, Sonya L Cyr, Ana Beatris Rossi
Dupilumab in Adults with Moderate-to-Severe Atopic Dermatitis and Prior Use of Systemic Non-Steroidal Immunosuppressants: Analysis of Four Phase 3 Trials. Dermatology and therapy 11 (4) (2021)
Laura K Ferris, Elyssa Ott, Jingzhi Jiang, H Chih-Ho Hong, Shu Li, Chenglong Han, Wojciech Baran
Efficacy and safety of guselkumab, administered with a novel patient-controlled injector (One-Press), for moderate-to-severe psoriasis: results from the phase 3 ORION study. The Journal of dermatological treatment 31 (2) (2019)